This company combines impressive quality with a generous valuation: VistaGen Therapeutics Inc. (VTGN)

In the latest session, VistaGen Therapeutics Inc. (NASDAQ: VTGN) closed at $0.15 down -3.06% from its previous closing price of $0.15. In other words, the price has decreased by -$0.0046 from its previous closing price. On the day, 1235596 shares were traded. VTGN stock price reached its highest trading level at $0.1560 during the session, while it also had its lowest trading level at $0.1422.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".



For a deeper understanding of VistaGen Therapeutics Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.10 and its Current Ratio is at 6.10. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 18 when GIN JERRY B bought 100,000 shares for $0.18 per share. The transaction valued at 17,870 led to the insider holds 100,000 shares of the business.

GIN JERRY B bought 100,000 shares of VTGN for $17,870 on Aug 18. The Director now owns 100,000 shares after completing the transaction at $0.18 per share. On Aug 17, another insider, Singh Shawn, who serves as the CHIEF EXECUTIVE OFFICER of the company, bought 600,000 shares for $0.17 each. As a result, the insider paid 103,200 and bolstered with 626,234 shares of the company.

Stock Price History:

Over the past 52 weeks, VTGN has reached a high of $1.79, while it has fallen to a 52-week low of $0.08. The 50-Day Moving Average of the stock is 0.1832, while the 200-Day Moving Average is calculated to be 0.3127.

Shares Statistics:

For the past three months, VTGN has traded an average of 6.83M shares per day and 2.34M over the past ten days. A total of 206.84M shares are outstanding, with a floating share count of 205.00M. Insiders hold about 0.30% of the company’s shares, while institutions hold 28.90% stake in the company. Shares short for VTGN as of Jan 12, 2023 were 12.4M with a Short Ratio of 7.30M, compared to 11.28M on Dec 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 6.00% and a Short% of Float of 6.03%.

Earnings Estimates

There are 2 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.08, while EPS last year was -$0.09. The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.03 and low estimates of -$0.03.

Analysts are recommending an EPS of between -$0.26 and -$0.34 for the fiscal current year, implying an average EPS of -$0.3. EPS for the following year is -$0.25, with 2 analysts recommending between -$0.15 and -$0.36.

Revenue Estimates

For the next quarter, 1 analysts are estimating revenue of $180k, a decrease of -41.90% less than the figure of $130.80% in the same quarter last year. There is a high estimate of $180k for the next quarter, whereas the lowest estimate is $180k.

A total of 1 analysts have provided revenue estimates for VTGN’s current fiscal year. The highest revenue estimate was $40k, while the lowest revenue estimate was $40k, resulting in an average revenue estimate of $40k. In the same quarter a year ago, actual revenue was $1.11M, down -96.40% from the average estimate.